203 related articles for article (PubMed ID: 28619234)
21. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Reinert RR
Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
[TBL] [Abstract][Full Text] [Related]
22. [Pneumococcal vaccines in children: an update].
Potin M
Rev Chilena Infectol; 2014 Aug; 31(4):452-6. PubMed ID: 25327199
[TBL] [Abstract][Full Text] [Related]
23. A 10-valent conjugate vaccine for some countries.
Prescrire Int; 2011 Jan; 20(112):8. PubMed ID: 21462783
[No Abstract] [Full Text] [Related]
24. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
Giglio N; Micone P; Gentile A
Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
[TBL] [Abstract][Full Text] [Related]
25. [Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].
de Arístegui Fernández J; Corretger Rauet JM; García Martín F; Hernández-Sampelayo T; Moraga Llop FA; Rodrigo Gonzalo De Liria C; Ruiz Contreras J;
An Esp Pediatr; 2002 Jan; 56(1):79-90. PubMed ID: 11792258
[TBL] [Abstract][Full Text] [Related]
26. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
[TBL] [Abstract][Full Text] [Related]
27. Promises and pitfalls of live attenuated pneumococcal vaccines.
Rosch JW
Hum Vaccin Immunother; 2014; 10(10):3000-3. PubMed ID: 25483458
[TBL] [Abstract][Full Text] [Related]
28. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
Gladstone RA; Jefferies JM; Faust SN; Clarke SC
Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969
[TBL] [Abstract][Full Text] [Related]
29. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
van Werkhoven CH
Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
[TBL] [Abstract][Full Text] [Related]
30. How many is enough? Will conjugated pneumococcal vaccines with more serotypes and fewer doses work better?
Lu CY; Huang LM
J Formos Med Assoc; 2011 Feb; 110(2):67-9. PubMed ID: 21377059
[No Abstract] [Full Text] [Related]
31. Immunisation with a pneumococcal 7-valent conjugate vaccine.
Dagan R
Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
33. Increasing focus on local epidemiology demonstrates potential value of pneumococcal conjugate vaccines in Middle East and North Africa Region.
Pelton SI
Vaccine; 2012 Dec; 30 Suppl 6():G1. PubMed ID: 23228351
[No Abstract] [Full Text] [Related]
34. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
35. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
36. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
37. A pain in the ear: what has the 7-valent conjugated pneumococcal vaccine done to reduce the incidence of acute otitis media?
Regelmann WE
Clin Infect Dis; 2005 Jun; 40(12):1745-7. PubMed ID: 15909261
[No Abstract] [Full Text] [Related]
38. Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice.
Azzari C; Martinón-Torres F; Schmitt HJ; Dagan R
Pediatr Infect Dis J; 2014 Aug; 33(8):858-64. PubMed ID: 24618937
[TBL] [Abstract][Full Text] [Related]
39. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.
Wagenvoort GH; Sanders EA; Vlaminckx BJ; de Melker HE; van der Ende A; Knol MJ
Euro Surveill; 2017 Mar; 22(10):. PubMed ID: 28300529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
